""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_component_original"	"response_comp_orig_cnt"	"response_component"	"response_comp_cnt"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"baseline_time"	"comparison"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"cohort"	"adjuvant"	"route"	"publication_reference"	"publication_year"	"signature_source"	"signature_source_url"	"comments"	"is_model"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subm_obs_id"	"uniq_obs_id"	"row_key"	"signature_file"	"signature_file_complete"
"subject"	""	""	""	"cell_subset"	""	""	"gene"	""	""	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"file"	"file"
"role"	""	""	""	"tissue"	"observed"	"observed"	"gene_biomarker"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"background"	"pathogen"	"background"	"background"	"vaccine"	"background"	"observed"	"background"	"background"	"background"	"background"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"background"	"observed"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response component (original gene symbol)"	"response component (original) count"	"response component (gene symbol)"	"response component count"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"baseline time"	"comparison"	"target pathogen"	"vaccine year (influenza only)"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"cohort"	"adjuvant"	"route"	"publication reference (PMID)"	"publication year"	"signature source figure, table or text section "	"signature source url"	"comments and additional details"	"gene signature is a model"	"Qi et al. (2016) Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598' target='_blank'>27030598</a>"	"age group"	"min. age"	"max. age"	"age units"	"ID of observation within its own submission"	"Uniq ID of observation within its submission type"	"row key"	"signature response component (genes) file"	" signature response components including non-HGNC genes"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBV10-3"	"8"	"TRBV10-3"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBV14"	"8"	"TRBV14"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBV15"	"8"	"TRBV15"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBV19"	"8"	"TRBV19"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBV20-1"	"8"	"TRBV20-1"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBV4-3"	"8"	"TRBV4-3"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBV5-3"	"8"	"TRBV5-3"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
""	"hipc_gene_27030598_3"	"2016.03"	"hipc_gene_27030598_3"	"naive T cell"	"TRBJ2-1"	"8"	"TRBJ2-1"	"8"	"gene expression"	"down"	"none"	"7 to 9"	"Days"	"time of vaccination (first dose)"	"CD4-positive T cell vs naive CD4-positive T cell"	"human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"seniors (52-75)"	""	""	"27030598"	"2016"	"Table S3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/bin/NIHMS784868-supplement-Supplemental_Text_and_Figures.pdf' target='_blank'>supplement-Supplemental_Text_and_Figures.pdf</a>"	"Table S3. BV and BJ gene segment usage in VZV-reactive CD4 T cells compared to naive and memory CD4 T cells (FDR <= 0.1)."	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=27030598"	"adults, seniors"	"52"	"75"	"years"	"3"	"312"	"27030598_3_312"	"hipc_gene_sig_27030598_3.txt"	"hipc_gene_sig_complete_27030598_3.txt"
